Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function

Abstract

Background:

Myocardial fibrosis is one of the mechanisms underlying left ventricular (LV) dysfunction in obese patients and may result from dysregulation of extracellular matrix (ECM) turnover. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) represent a regulatory system playing a crucial role in ECM metabolism.

Objectives:

We sought to assess plasma levels of MMP-2, MMP-9, TIMP-1 and TIMP-2 in obese young women and to evaluate the association between MMP/TIMP system components and LV function in this population.

Design:

Prospective, cross-sectional study.

Setting:

University hospital.

Patients:

Seventy-one women aged <35 years with body mass index >30 kg m−2 and 30 healthy slim female controls.

Main outcome measures:

Plasma MMP-2, MMP-9, TIMP-1 and TIMP-2 measurements and echocardiographic studies, including LV strain/strain rate evaluation.

Results:

We demonstrated increased levels of MMP-9 and TIMP-1 and decreased MMP-2 in the obese population. LV dysfunction shown in patients with obesity was characterized by significantly lower values of strain/strain rate parameters. Plasma MMP-2 correlated positively and TIMP-1 negatively with systolic strain (r=0.39, P<0.001 and r=−0.40, P<0.001, respectively), peak systolic strain rate (r=0.38, P<0.001 and r=−0.27, P<0.03, respectively) and peak early diastolic strain rate (r=0.40, P<0.001 and r=−0.24, P<0.05, respectively). Plasma MMP-2, fasting insulin and body mass index proved the only independent determinants of strain/strain rate parameters of LV systolic and diastolic performance in obese subjects.

Conclusions:

In premenopausal obese women (1) plasma MMP/TIMP profile is altered, (2) abnormalities of LV function are related to the changes in the MMP/TIMP system that might promote attenuated ECM degradation, mainly to the downregulation of MMP-2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP . The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195–1200.

    Article  CAS  Google Scholar 

  2. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–313.

    Article  Google Scholar 

  3. Dollery CM, McEwan JR, Henney AM . Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863–868.

    Article  CAS  Google Scholar 

  4. McCawley L, Matrisian L . Matrix metalloproteinases: they're not just for matrix anymore!. Cur Opin Cell Biol 2001; 13: 534–540.

    Article  CAS  Google Scholar 

  5. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases. Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089–2096.

    Article  CAS  Google Scholar 

  6. Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J . Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 2006; 48: 89–96.

    Article  CAS  Google Scholar 

  7. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003; 108: 1455–1460.

    Article  CAS  Google Scholar 

  8. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM . Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Failure 2004; 10: 328–333.

    Article  CAS  Google Scholar 

  9. Wang W, Schulze C, Suarez-Pinzon WL, Dyck JRB, Sawicki G, Schulz R . Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002; 106: 1543–1549.

    Article  CAS  Google Scholar 

  10. Tayebjee MH, Lim HS, Nadar S, MacFadyen RJ, Lip GYH . Tissue inhibitor of metalloproteinase-1 is a marker of diastolic dysfunction using tissue Doppler in patients with type 2 diabetes and hypertension. Eur J Clin Invest 2005; 35: 8–12.

    Article  CAS  Google Scholar 

  11. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR . Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093–1101.

    Article  CAS  Google Scholar 

  12. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888–11896.

    Article  CAS  Google Scholar 

  13. Utian WH . The International Menopause Society menopause-related terminology definitions. Climacteric 1999; 2: 284–286.

    Article  CAS  Google Scholar 

  14. Sahn DJ, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  Google Scholar 

  15. De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH . Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23: 600–606.

    Article  CAS  Google Scholar 

  16. Spinale FG . Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002; 90: 520–530.

    Article  CAS  Google Scholar 

  17. Chapman RE, Spinale FG . Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications. Am J Physiol 2004; 286: H1–H10.

    Article  CAS  Google Scholar 

  18. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, Smolen J et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181–2187.

    Article  CAS  Google Scholar 

  19. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J . Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004; 44: 1609–1618.

    Article  CAS  Google Scholar 

  20. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley III AJ, Spinale FG . Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998; 97: 1708–1715.

    Article  CAS  Google Scholar 

  21. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368–372.

    Article  CAS  Google Scholar 

  22. Tazaki T, Minoguchi K, Yokoe T, Samson KTR, Minoguchi H, Tanaka A et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170: 1354–1359.

    Article  Google Scholar 

  23. Lewandowski KC, Komorowski J, O'Callaghan CJ, Tan BK, Chen J, Prelevic GM et al. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 1173–1177.

    Article  CAS  Google Scholar 

  24. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P . Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110: 1564–1571.

    Article  CAS  Google Scholar 

  25. Laimer M, Kaser S, Kranebitter M, Sandhofer A, Muhlmann G, Schwelberger H et al. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes Relat Metab Disord 2005; 29: 498–501.

    Article  CAS  Google Scholar 

  26. Glowinska-Olszewska B, Urban M . Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 2007; 56: 799–805.

    Article  CAS  Google Scholar 

  27. Shirwany A, Weber KT . Extracellular matrix remodeling in hypertensive heart disease. J Am Coll Cardiol 2006; 48: 97–98.

    Article  CAS  Google Scholar 

  28. Zaman T, Fujii S, Goto D, Furomoto T, Mishima T, Nakai Y et al. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol 2004; 37: 525–535.

    Article  CAS  Google Scholar 

  29. Tsutsui H, Matsushima S, Kinugawa S, Ide T, Inoue N, Ohta Y et al. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertens Res 2007; 30: 439–449.

    Article  CAS  Google Scholar 

  30. Marwick TH, Wong CY . Role of exercise and metabolism in heart failure with normal ejection fraction. Prog Cardiovasc Dis 2007; 49: 263–274.

    Article  Google Scholar 

  31. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH . Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081–3087.

    Article  Google Scholar 

  32. Tayebjee MH, Nadar SK, MacFadyen RJ, Lip GYH . Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension. Relationship to tissue Doppler indices of diastolic relaxation. Am J Hypertens 2004; 17: 770–774.

    CAS  PubMed  Google Scholar 

  33. Noji Y, Shimizu M, Ino H, Higashikata T, Yamaguchi M, Nohara A et al. Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction. Circ J 2004; 68: 355–360.

    Article  CAS  Google Scholar 

  34. Lindsay MM, Maxwell P, Dunn FG . TIMP-1. A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136–141.

    Article  CAS  Google Scholar 

  35. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004; 109: 2191–2196.

    Article  Google Scholar 

  36. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B et al. Alterations in left ventricular structure and function in young healthy obese women. J Am Coll Cardiol 2004; 43: 1399–1404.

    Article  Google Scholar 

  37. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Di Mario U, Leonetti F . Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obes Res 2004; 12: 1616–1621.

    Article  Google Scholar 

  38. Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG et al. Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr 2006; 19: 1063–1071.

    Article  Google Scholar 

  39. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899–907.

    Article  CAS  Google Scholar 

  40. Ahima RS . Adipose tissue as an endocrine organ. Obesity 2006; 14 (Suppl 5): 242S–249S.

    Article  CAS  Google Scholar 

  41. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND et al. Effects of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 2006; 100: 1657–1665.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Kosmala.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kosmala, W., Plaksej, R., Przewlocka-Kosmala, M. et al. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Int J Obes 32, 763–771 (2008). https://doi.org/10.1038/sj.ijo.0803794

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803794

Keywords

This article is cited by

Search

Quick links